Epithelial and stromal genetic instability linked to tumor suppressor genes in ulcerative colitis-associated tumorigenesis

References

• Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994; 107: 369–78
   PubMed Web of Science ®Google Scholar
• Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000; 60: 3333–7
   PubMed Web of Science ®Google Scholar
• Yoshida T, Mikami T, Mitomi H, Okayasu I. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts. J Pathol 2003; 199: 166–75
   PubMedGoogle Scholar
• Yoshida T, Haga S, Numata Y, Yamashita K, Mikami T, Ogawa T, et al. Disruption of the p53–p53R2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis. Int J Cancer 2006; 118: 1395–403
   PubMedGoogle Scholar
• Matsumoto N, Yoshida T, Okayasu I. High epithelial and stromal genetic instability of chromosome 17 in ulcerative colitis-associated carcinogenesis. Cancer Res 2003; 63: 6158–61
   Google Scholar
• Yin J, Harpaz N, Tong Y, Huang Y, Laurin J, Greenwald BD, et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993; 104: 1633–9
   PubMed Web of Science ®Google Scholar
• Yoshida T, Matsumoto N, Mikami T, Okayasu I. Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours. Br J Cancer 2004; 91: 1081–8
   PubMedGoogle Scholar
• Matsumoto N, Yoshida T, Yamashita K, Numata Y, Okayasu I. Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma. Br J Cancer 2003; 89: 707–12
   PubMed Web of Science ®Google Scholar
• Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248–57
   PubMed Web of Science ®Google Scholar
• Wang S, Mori Y, Sato F, Yin J, Xu Y, Zou TT, et al. An LOH and mutational investigation of the ST7 gene locus in human esophageal carcinoma. Oncogene 2003; 22: 467–70
   PubMedGoogle Scholar
• Ogawa T, Yoshida T, Tsuruta T, Saigenji K, Okayasu I. Genetic instability on chromosome 17 in the epithelium of non-polypoid colorectal carcinomas compared to polypoid lesions. Cancer Sci 2006; 97: 1335–42
   PubMedGoogle Scholar
• Paoloni-Giacobino A, Rey-Berthod C, Couturier A, Antonarakis SE, Hutter P. Differential rates of frameshift alterations in four repeat sequences of hereditary nonpolyposis colorectal cancer tumors. Hum Genet 2002; 111: 284–9
   PubMedGoogle Scholar
• Vassileva V, Millar A, Briollais L, Chapman W, Bapat B. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. Cancer Res 2002; 62: 4095–9
   PubMed Web of Science ®Google Scholar
• Riccio A, Aaltonen LA, Godwin AK, Loukola A, Percesepe A, Salovaara R, et al. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet 1999; 23: 266–8
   PubMedGoogle Scholar
• Sinicrope FA, Lemoine M, Xi L, Lynch PM, Cleary KR, Shen Y, et al. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers. Gastroenterology 1999; 117: 350–8
   PubMed Web of Science ®Google Scholar
• Ishiguro K, Yoshida T, Yagishita H, Numata Y, Okayasu I. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Gut 2006; 55: 695–702
   PubMed Web of Science ®Google Scholar
• Brentnall T, Crispin D, Bronner M, Cherian S, Hueffed M, Rabinovitch P, et al. Microsatellite instability in non-neoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996; 56: 1237–40
   PubMed Web of Science ®Google Scholar
• Schulmann K, Mori Y, Croog V, Yin J, Olaru A, Sterian A, et al. Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. Gastroenterology 2005; 129: 74–85
   PubMed Web of Science ®Google Scholar
• Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M, Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 1998; 58: 3942–5
   PubMed Web of Science ®Google Scholar
• Mikami T, Yoshida T, Numata Y, Shiraishi H, Araki K, Guiot M-C, et al. Low frequency of promoter methylation of O6-methylguanine DNA methyltransferase and hMLH1 in ulcerative colitis-associated tumors. Am J Clin Pathol 2007; 127: 366–73
   PubMedGoogle Scholar
• Massague J. How cells read TGF-beta signals. Natl Rev Mol Cell Biol 2000; 1: 169–78
   PubMed Web of Science ®Google Scholar
• Terdiman JP, Aust DE, Chang CG, Willenbucher RF, Baretton GB, Waldman FM. High resolution analysis of chromosome 18 alterations in ulcerative colitis-related colorectal cancer. Cancer Genet Cytogenet 2002; 136: 129–37
   PubMedGoogle Scholar
• Yamashita K, Yasuda S, Kuba T, Otani Y, Fujiwara M, Okayasu I. Unique characteristics of rectal carcinoma cell lines derived from invasive carcinomas in ulcerative colitis patients. Cancer Sci 2004; 95: 211–7
   PubMedGoogle Scholar
• Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285–96
   PubMed Web of Science ®Google Scholar
• Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNF-alpha to TRAIL-mediated tumor regression. Cancer Cell 2004; 6: 297–305
   PubMed Web of Science ®Google Scholar
• Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461–6
   PubMed Web of Science ®Google Scholar